BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30233199)

  • 1. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
    Antwi-Boasiako C; Campbell AD
    Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease.
    Antwi-Boasiako C; Dankwah GB; Aryee R; Hayfron-Benjamin C; Aboagye G; Campbell AD
    J Clin Lab Anal; 2020 Jul; 34(7):e23294. PubMed ID: 32170816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of sociodemographic, clinical, and laboratory markers of sickle leg ulcers among young nigerians at a tertiary health institution.
    Olatunya OS; Albuquerque DM; Adekile AD; Costa FF
    Niger J Clin Pract; 2018 Jul; 21(7):882-887. PubMed ID: 29984720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of Soluble Endothelium Adhesion Molecules and Complications among Sickle Cell Disease Patients in Ghana.
    Antwi-Boasiako C; Donkor ES; Sey F; Dzudzor B; Dankwah GB; Otu KH; Doku A; Dale CA; Ekem I
    Diseases; 2018 Apr; 6(2):. PubMed ID: 29690499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
    Landburg PP; Teerlink T; Biemond BJ; Brandjes DP; Muskiet FA; Duits AJ; Schnog JB;
    Blood Cells Mol Dis; 2010 Apr; 44(4):229-32. PubMed ID: 20185345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.
    Lopez BL; Kreshak AA; Morris CR; Davis-Moon L; Ballas SK; Ma XL
    Br J Haematol; 2003 Feb; 120(3):532-4. PubMed ID: 12580975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Al Najjar S; Adam S; Ahmed N; Qari M
    Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Soluble Endothelial Adhesion Molecules and Nitric Oxide Metabolites in Sickle Cell Disease.
    Antwi-Boasiako C; Ahenkorah J; Donkor ES; Dzudzor B; Dankwah GB; Otu KH; Aryee R; Hayfron-Benjamin C; Campbell AD
    Med Sci (Basel); 2018 Dec; 7(1):. PubMed ID: 30577523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
    Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
    Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
    Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Strunk C; Piccone CM; Manwani D; Boruchov D; Farooq F; Urbonya R; Wilson S; Boatemaa GD; Perrotta S; Sainati L; Rivers A; Rao S; Zempsky W; Ekem I; Sey F; Segbefia C; Inusa B; Tartaglione I; Campbell AD
    Ann Hematol; 2020 Sep; 99(9):2073-2079. PubMed ID: 32377816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.
    Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA
    Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients.
    Antwi-Boasiako C; Frimpong E; Gyan B; Kyei-Baafour E; Sey F; Dzudzor B; Abdul-Rahman M; Dankwah GB; Otu KH; Ndanu TA; Campbell AD; Ekem I; Donkor ES
    Med Sci (Basel); 2018 Jun; 6(3):. PubMed ID: 29954157
    [No Abstract]   [Full Text] [Related]  

  • 15. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
    Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematological parameters in Ghanaian sickle cell disease patients.
    Antwi-Boasiako C; Ekem I; Abdul-Rahman M; Sey F; Doku A; Dzudzor B; Dankwah GB; Otu KH; Ahenkorah J; Aryee R
    J Blood Med; 2018; 9():203-209. PubMed ID: 30464671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Yildirim N; Unal S; Yalcinkaya A; Karahan F; Oztas Y
    Ann Hematol; 2022 Jan; 101(1):35-41. PubMed ID: 34564750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
    Landburg PP; Teerlink T; Muskiet FA; Duits AJ; Schnog JJ;
    Am J Hematol; 2008 Jul; 83(7):577-9. PubMed ID: 18383318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.